Lv11
30 积分 2026-01-29 加入
Safety and Efficacy of GEMOX Combined With Donafenib and Tislelizumab as First-line Treatment in Biliary Tract Cancer
2小时前
求助中
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
2小时前
已完结
If your organization or you do not have a subscription, try one of the following: Contacting your organization’s admin about adding this content to your AdisInsight subscription Buying a PDF version of any individual profile Request a free trial
2小时前
求助中